MKS宣布向Sartorius Stedim Biotech出售数据分析解决方案业务

red

MKS Announces Sale of Data Analytics Solutions Business to Sartorius Stedim Biotech

      Andover, Mass， April 03, 2017 (GLOBE NEWSWIRE) -- MKS Instruments, Inc. (NASDAQ:MKSI), a global provider of technologies that enable advanced processes and improve productivity, today announced that it has completed the sale of its Data Analytics Solutions business to Sartorius Stedim Biotech (Euronext ParisIM), a leading supplier to the biopharmaceutical industry, for $72.5 million on a cash and debt-free basis.

     Andover, Mass，2017年4月03日（全球新闻网） - MKS Instruments，Inc.（纳斯达克股票代码：MKSI）是全球提供高级流程和提高生产力的技术提供商，今天宣布已经完成了其数据分析 以现金和无债务为基础，以7250万美元的价格出售给以生物制药行业的领先供应商Sartorius Stedim Biotech（泛欧交易所巴黎：DIM）解决方案业务。

     MKS Data Analytics Solutions is a software business based in Malmö, Sweden that MKS acquired in 2006. The business develops and markets multivariate data analysis and modeling software particularly used by biotechnology and pharmaceutical companies and generated revenue of approximately $13 million in 2016.

    MKS数据分析解决方案是一家位于瑞典马尔默的软件业务，MKS于2006年收购。该业务开发和销售生物技术和制药公司特别使用的多变量数据分析和建模软件，并在2016年创造了约1300万美元的收入。